An evaluation study of the impact of the Axomove Therapy® medical device on subacute or chronic low back pain patients leaving rehabilitation centres to facilitate self-rehabilitation. A prospective, randomized, open-label, multicentre study whose main objective is to evaluate the effectiveness of the Axomove Therapy Medical Device on disability reduction (Oswestry disability index score) patients with subacute or chronic low back pain requiring rehabilitation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
190
Personalized exercise programs for the self-rehabilitation of low back pain patients
CHRU de LILLE
Lille, France
RECRUITINGEfficacy of AXOMOVE Therapy
Functional capacity of patients measured through the Oswestry Disability Index score
Time frame: 14 weeks (105 days)
Level of patient physical activity
Level of physical activity measured by the international physical activity questionnaire (IPAQ-SF)
Time frame: day 0 (inclusion), day 15, day 45 and day 105
Quality of life
Quality of life measured by the EQ5D5L questionnaire
Time frame: day 0 (inclusion), day 15, day 45 and day 105
Quality of life
Quality of life measured by the SF36 questionnaire
Time frame: day 0 (inclusion), day 15, day 45 and day 105
Efficacy of AXOMOVE Therapy
Functional capacity of patients measured through the Oswestry Disability Index score (ODI)
Time frame: day 0 (inclusion), day 15, day 45
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.